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Table S1.  The concentration of Au NPs leading to 50 % cell growth inhibition (IC50) in human and 
mouse cancer cells.
Hep G2
(µg/mL)
Caco-2
(µg/mL)
PC3
(µg/mL)
B16F10
(µg/mL)
CT26
(µg/mL)
20 nm Au-CATB 3.1 3.7 2 3.5 3.5
60 nm Au-CATB 3.2 3.4 3.5 3.8 3.8
RG5 AuNPs-Lcysteine 6.8 7.8 8.2 9.2 8.2 
RG7 AuNPs-Lcysteine 7.2 8.8 7.8 8.9 8.1
RG8 AuNPs-Lcysteine 7.1 8.5 8.2 8.5 9.0
RG9 AuNPs-Lcysteine 6.7 8.7 7.4 9.4 8.7
RG11 AuNPs-Lcysteine 6.9 9.0 8.5 9.1 8.4
RG12 AuNPs-Lcysteine 7.0 8.7 8.0 8.4 9.1 
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Figure S1.  TEM (seeds, GR1 and GR2) and SEM of Au-L-cysteine nanoparticles produced in this 
study and not used in the cytotoxicity assays, with mean diameters of (seeds) ~2 nm, (GR1) ~ 4 nm, 
(GR2) ~5.5 nm, (GR3) ~ 7 nm, (GR4) ~9 nm, (GR6) ~46 nm, (GR10) ~118 nm.  The sample (Au NPs-
CTAB) ~60 nm was used as negative control for cytotoxicity comparison study.
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Figure S2.  (a) Size distribution by intensity for Au NPs-L-cysteine methyl ester hydrochloride sanples 
produced in this study and used for cytotoxicity assay. (b) and (c) Zeta potential of Au-L-cysteine 
4
nanoparticles.  The sample (Au NPs-CTAB) ~60 nm was used as negative control for cytotoxicity 
study.
Figure S3. Complexation of siRNA (0.25 μg) with a GR8 nanoparticle sample at different mass ratios 
(MRs of Au to siRNA, MR = 5, 10 and 20).  0.25 μg of siRNA was used as negative control.
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Figure S4. The representative Dot Plots showing fluorescein-positive cells (%) resulting from 
fluorescein-siRNA (20 nM) either uncomplexed or complexed with GR11 (MR20) and INTERFERinTM.  
We noted that samples of Au NPs- L-cysteine (GR1-GR4) were stable for more than two weeks, whilst 
GR5-GR12 solutions were stable for more than four month when stored at 4 C.  Moreover, Au NP- L-
cysteine samples with bigger diameters precipitate by gravity but could be redispersed easily with 
shaking without noticeable aggregation.
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